USFDA seeks voluntary action at Dr. Reddy's Andhra Pradesh facility

17 Feb 2020 Evaluate

The US Food and Drug Administration (USFDA) has asked Dr. Reddy's Laboratories to initiate voluntary action at its Duvvada facility in Andhra Pradesh. The company has been notified by the USFDA that the inspection classification of the Formulations Manufacturing Plant at Duvvada, Visakhapatnam is determined as Voluntary Action Initiated (VAI).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1166.00 -0.45 (-0.04%)
20-Jan-2026 09:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1661.80
Dr. Reddys Lab 1166.00
Cipla 1387.50
Zydus Lifesciences 880.35
Lupin 2168.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×